EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Implementing plasma p‐tau217 and cognitive testing for Alzheimer's screening in low‐education populations in central China

Shuai Chen, Xiaodi Hao, Kai Ma, Rong Li, Changming Wen, Xinsheng Han, Wenquan Zheng, Shiwang Ruan, Shude You, Wenfeng An, Zhihui Qi, Kai Wang und 7 weitere

Alzheimer's & Dementia · 2026-03 · 22 (3)

DOI: 10.1002/alz.71251 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 10.03.2026. Verfasst von Shuai Chen und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Zhengzhou University People's Hospital (Henan Provincial People's Hospital), Zhengzhou, China. Hauptthemen laut MEDLINE: tau Proteins, Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Henan Province Key R&D Program, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION We evaluated a pragmatic screening strategy combining brief cognitive assessment with plasma phosphorylated tau217 ( p ‐tau217) in an elderly health screening cohort. METHODS Participants completed the Memory and Executive Screening (MES) test and plasma biomarker assessment. Cognitive impairment was defined using individualized residual norms derived from an internal reference sample. The p ‐tau217 thresholds were positive predictive value (PPV) ‐oriented and anchored to age‐ and cognitive status‐specific prior probabilities of amyloid‐ β (A β ) pathology. RESULTS MES‐defined cognitive impairment (≤−2 standard deviation [SD] deviation after adjustment for demographics) was identified in 12.4% of participants. In cognitively unimpaired (CU) individuals, age‐specific thresholds targeting a PPV of 0.7 yielded an overall p ‐tau217 positivity rate of 11.8%, increasing from 3.5% (< 60 years) to 6.3% (60–70 years) and 25.9% (≥70 years). Among cognitively impaired (CI) participants, 26.6% were p ‐tau217 positive. DISCUSSION This framework supports practical integration of plasma biomarkers into community‐based screening, with longitudinal follow‐up needed to further refine threshold selection. Highlights Regression‐based residual method reduced education bias, identifying 12.4% with cognitive impairment individuals. Fully automated chemiluminescent assay enabled practical, large‐scale biomarker implementation. Brief screening strategy supports early detection, clinical trial recruitment, and resource allocation in under‐resourced regions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

tau ProteinsAlzheimer DiseaseCognitive DysfunctionHumansFemaleBiomarkersMaleAgedChinaNeuropsychological TestsMiddle AgedEducational StatusMass ScreeningPhosphorylation

Stichwörter der Autor:innen

Alzheimer's diseaseAβ risk stratificationp‐tau217 testingscreening strategy

Substanzen

tau ProteinsBiomarkers

Autor:innen und Institutionen

  • Department of Neurology, Zhengzhou University People's Hospital (Henan Provincial People's Hospital), Zhengzhou, China.
  • Department of Neurology, Nanyang Central Hospital, Nanyang, Henan, China.
  • Department of Neurology, Kaifeng Central Hospital, Kaifeng, China.
  • Department of Neurology, Pingmei Shenma Medical Group General Hospital, Pingdingshan, Henan, China.
  • Department of Neurology, Zhumadian Central Hospital, Zhumadian, Henan, China.
  • Department of Neurology, Xuchang Central Hospital, Xuchang, Henan, China.

Förderung

  • Henan Province Key R&D Program
  • National Natural Science Foundation of China

Zitieren

APA

Chen, S., Hao, X., Ma, K., Li, R., Wen, C., Han, X., Zheng, W., Ruan, S., You, S., An, W., Qi, Z., Wang, K., He, W., Duan, Z., Wang, F., Shang, J., Cao, L., Hao, Y., & Zhang, J. (2026). Implementing plasma p‐tau217 and cognitive testing for Alzheimer's screening in low‐education populations in central China. Alzheimer's & Dementia, 22(3). https://doi.org/10.1002/alz.71251

Vancouver

Chen S, Hao X, Ma K, Li R, Wen C, Han X, et al. Implementing plasma p‐tau217 and cognitive testing for Alzheimer's screening in low‐education populations in central China. Alzheimer's & Dementia. 2026;22(3). doi:10.1002/alz.71251

BibTeX
@article{Chen2026,
  author = {Chen, Shuai and Hao, Xiaodi and Ma, Kai and Li, Rong and Wen, Changming and Han, Xinsheng and Zheng, Wenquan and Ruan, Shiwang and You, Shude and An, Wenfeng and Qi, Zhihui and Wang, Kai and He, Wenlong and Duan, Zhihui and Wang, Fengyu and Shang, Junkui and Cao, Lin and Hao, Yibin and Zhang, Jiewen},
  title = {Implementing plasma p‐tau217 and cognitive testing for Alzheimer's screening in low‐education populations in central China},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  volume = {22},
  number = {3},
  doi = {10.1002/alz.71251}
}
Kostenlos starten →